Fitzgerald, A. A., Li, E., & Weiner, L. M. (Jan. 2021). 3D Culture Systems for Exploring Cancer Immunology. Cancers, 13(1), 56. https://doi.org/10.3390/cancers13010056

Scherer, W. F., Syverton, J. T., Gey, G. O., & STUDIES ON THE PROPAGATION IN VITRO OF POLIOMYELITIS VIRUSES: IV. VIRAL MULTIPLICATION IN A STABLE STRAIN OF HUMAN MALIGNANT EPITHELIAL CELLS (STRAIN HELA) DERIVED FROM AN EPIDERMOID CARCINOMA OF THE CERVIX. (May 1953). Journal Of Experimental Medicine, 97, 5, 695–710, doi: https://doi.org/10.1084/jem.97.5.695.

Kapałczyńska, M. (2018). Jun., 2D and 3D cell cultures – a comparison of different types of cancer cell cultures, Arch Med Sci, vol. 14, no. 4, pp. 910–919. https://doi.org/10.5114/aoms.2016.63743

Sharma, S. V., Haber, D. A., & Settleman, J. (Apr. 2010). Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents. Nature Reviews Cancer, 10(4), 241–253. https://doi.org/10.1038/nrc2820

Jubelin, C., et al. (Sep. 2022). Three-dimensional in vitro culture models in oncology research. Cell & Bioscience, 12(1), 155. https://doi.org/10.1186/s13578-022-00887-3

Zhang, C. Y., Liu, S., & Yang, M. (2022). Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy, World Journal of Gastroenterology, vol. 28, no. 27, pp. 3346–3358, Jul. https://doi.org/10.3748/wjg.v28.i27.3346

Han, S., & Wu, J. (Nov. 2022). Three-dimensional (3D) scaffolds as powerful weapons for tumor immunotherapy. Bioactive Materials, 17, 300–319. https://doi.org/10.1016/j.bioactmat.2022.01.020

Zhou, Z., et al. (Jan. 2024). Harnessing 3D in vitro systems to model immune responses to solid tumors: a step toward improving and creating personalized immunotherapies. Nature Reviews Immunology, 24(1), 18–32. https://doi.org/10.1038/s41577-023-00896-4

Orangi, M. (2016). Cytotoxic and Apoptotic Activities of Methanolic Subfractions of Scrophularia oxysepala against Human Breast Cancer Cell Line, Evidence-Based Complementary and Alternative Medicine, vol. no. 1, p. 8540640, 2016. https://doi.org/10.1155/2016/8540640

Pilco-Ferreto, N., & Calaf, G. M. (Aug. 2016). Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. International Journal of Oncology, 49(2), 753–762. https://doi.org/10.3892/ijo.2016.3558

Abudayyeh, O. O., et al. (Oct. 2017). RNA targeting with CRISPR-Cas13. Nature, 550(7675), 280–284. https://doi.org/10.1038/nature24049

Qi, F., et al. (2019). A Synthetic Light-switchable System based on CRISPR Cas13a Regulates the Expression of LncRNA MALAT1 and Affects the Malignant Phenotype of Bladder Cancer Cells. International Journal Of Biological Sciences, 15(8), 1630–1636. https://doi.org/10.7150/ijbs.33772

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, Y., et al. (May 2025). Cancer research revolutionized: Unveiling the power of organoids and their therapeutic potential in oncology. hLife, 3(5), 216–236. https://doi.org/10.1016/j.hlife.2024.05.002

Kapałczyńska, M. (2018). Jun., 2D and 3D cell cultures – a comparison of different types of cancer cell cultures, Arch Med Sci, vol. 14, no. 4, pp. 910–919. https://doi.org/10.5114/aoms.2016.63743

Birgersdotter, A., Sandberg, R., & Ernberg, I. (2005). Gene expression perturbation in vitro—A growing case for three-dimensional (3D) culture systems, Seminars in Cancer Biology, vol. 15, no. 5, pp. 405–412, Oct. https://doi.org/10.1016/j.semcancer.2005.06.009

Li, C., Kato, M., Shiue, L., Shively, J. E., Ares, M., & Lin, R. J. (Feb. 2006). Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays. Cancer Research, 66(4), 1990–1999. https://doi.org/10.1158/0008-5472.can-05-2593

He, Y., et al. (Feb. 2026). CRISPR screening redefines therapeutic target identification and drug discovery with precision and scalability. Journal of Pharmaceutical Analysis, 16(2), 101357. https://doi.org/10.1016/j.jpha.2025.101357

Rolver, M. G., Elingaard-Larsen, L. O., & Pedersen, S. F. (Jun. 2019). Assessing Cell Viability and Death in 3D Spheroid Cultures of Cancer Cells. Journal of Visualized Experiments (JoVE), e59714. https://doi.org/10.3791/59714. no. 148.

Zanoni, M., et al. (Jan. 2016). 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Scientific Reports, 6(1), 19103. https://doi.org/10.1038/srep19103

Malik, P., & Mukherjee, T. K. (2023). Mammalian Cell Culture in Three Dimensions: Basic Guidelines. Practical Approach to Mammalian Cell and Organ Culture (pp. 637–685). Springer. https://doi.org/10.1007/978-981-19-1731-8_13-1

Zhao, Z. (2022). Dec., Organoids, Nat Rev Methods Primers, vol. 2, no. 1, p. 94. https://doi.org/10.1038/s43586-022-00174-y

Jubelin, C., et al. (Sep. 2022). Three-dimensional in vitro culture models in oncology research. Cell & Bioscience, 12(1), 155. https://doi.org/10.1186/s13578-022-00887-3

Kim, J., Koo, B. K., & Knoblich, J. A. (2020). Human organoids: model systems for human biology and medicine, Nat Rev Mol Cell Biol, vol. 21, no. 10, pp. 571–584, Oct. https://doi.org/10.1038/s41580-020-0259-3

Yang, S., et al. (2023). Organoids: The current status and biomedical applications. MedComm, 4(3), e274. https://doi.org/10.1002/mco2.274

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, D., Powell, E., Wan, K. M., Athavale, R., Loo, C., & Ford, C. E. (2024). Abstract B014: Patient-derived organoid models for drug screening in molecular subtypes of endometrial cancer, Clin Cancer Res, vol. 30, no. 5_Supplement, p. B014, Mar. https://doi.org/10.1158/1557-3265.ENDO24-B014

Habanjar, O., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (Jan. 2021). 3D Cell Culture Systems: Tumor Application, Advantages, and Disadvantages. International Journal of Molecular Sciences, 22(22), 12200. https://doi.org/10.3390/ijms222212200

Lo, Y. H., et al. (Aug. 2025). Large-scale CRISPR screening in primary human 3D gastric organoids enables comprehensive dissection of gene-drug interactions. Nature Communications, 16(1), 7566. https://doi.org/10.1038/s41467-025-62818-3

Skoufou-Papoutsaki, N., et al. (Oct. 2023). Efficient genetic editing of human intestinal organoids using ribonucleoprotein-based CRISPR. Dis Model Mech, 16(10), dmm050279. https://doi.org/10.1242/dmm.050279

Grinnell, F., & Petroll, W. M. (2010). Cell Motility and Mechanics in Three-Dimensional Collagen Matrices, Annual Review of Cell and Developmental Biology, vol. 26, no. Volume 26, pp. 335–361, Nov. 2010. https://doi.org/10.1146/annurev.cellbio.042308.113318

Liu, K., Mihaila, S. M., Rowan, A., Oosterwijk, E., & Kouwer, P. H. J. (2019). Synthetic Extracellular Matrices with Nonlinear Elasticity Regulate Cellular Organization, Biomacromolecules, vol. 20, no. 2, pp. 826–834, Feb. https://doi.org/10.1021/acs.biomac.8b01445

Ajjarapu, S. M., Tiwari, A., & Kumar, S. (2023). Applications and Utility of Three-Dimensional In Vitro Cell Culture for Therapeutics, Future Pharmacology, vol. 3, no. 1, pp. 213–228, Mar. https://doi.org/10.3390/futurepharmacol3010015

Calitz, C., et al. (Jan. 2023). Influence of extracellular matrix composition on tumor cell behavior in a biomimetic in vitro model for hepatocellular carcinoma. Scientific Reports, 13(1), 748. https://doi.org/10.1038/s41598-023-27997-3

Jung, M., Han, Y., Woo, C., & Ki, C. S. (2021). Pulmonary tissue-mimetic hydrogel niches for small cell lung cancer cell culture, J. Mater. Chem. B, vol. 9, no. 7, pp. 1858–1866, Feb. https://doi.org/10.1039/D0TB02609C

Luo, X., et al. (Sep. 2021). Hydrogel-based colorectal cancer organoid coculture models. Acta Biomaterialia, 132, 461–472. https://doi.org/10.1016/j.actbio.2020.12.037

Li, J. (2022). An Overview of Organs-on-Chips Based on Deep Learning, Research, vol. Jan. 2022. https://doi.org/10.34133/2022/9869518

Duzagac, F., Saorin, G., Memeo, L., Canzonieri, V., & Rizzolio, F. (2021). Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research, Cancers, vol. 13, no. 4, p. 737, Jan. https://doi.org/10.3390/cancers13040737

Leung, C. M., et al. (May 2022). A guide to the organ-on-a-chip. Nat Rev Methods Primers, 2(1), 33. https://doi.org/10.1038/s43586-022-00118-6

Paterson, K., Zanivan, S., Glasspool, R., Coffelt, S. B., & Zagnoni, M. (2021). Microfluidic technologies for immunotherapy studies on solid tumors, Lab Chip, vol. 21, no. 12, pp. 2306–2329, Jun. https://doi.org/10.1039/D0LC01305F

Schene, I. F., et al. (Oct. 2020). Prime editing for functional repair in patient-derived disease models. Nature Communications, 11, 5352. https://doi.org/10.1038/s41467-020-19136-7

Menche, C., & Farin, H. F. (Oct. 2021). Strategies for genetic manipulation of adult stem cell-derived organoids. Experimental & Molecular Medicine, 53(10), 1483–1494. https://doi.org/10.1038/s12276-021-00609-8

Cao, X., et al. (2026). Optimization of RNP-CRISPR for high-efficiency gene editing in mouse intestinal organoids. Mol Cell Biochem Feb. https://doi.org/10.1007/s11010-026-05492-3

Article  Google Scholar 

Sharpless, N. E., & DePinho, R. A. (2006). The mighty mouse: genetically engineered mouse models in cancer drug development, Nat Rev Drug Discov, vol. 5, no. 9, pp. 741–754, Sep. https://doi.org/10.1038/nrd2110

Singh, M., Murriel, C. L., & Johnson, L. (May 2012). Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes. Cancer Research, 72(11), 2695–2700. https://doi.org/10.1158/0008-5472.CAN-11-2786

Horii, T., Morita, S., Kimura, M., Terawaki, N., Shibutani, M., & Hatada, I. (Aug. 2017). Efficient generation of conditional knockout mice via sequential introduction of lox sites. Scientific Reports, 7(1), 7891. https://doi.org/10.1038/s41598-017-08496-8

Yu, S., et al. (Jan. 2010). Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice. PLoS One, 5(1), e8579. https://doi.org/10.1371/journal.pone.0008579

Hursting, S. D., et al. (Sep. 2004). Diet-gene interactions in p53-deficient mice: insulin-like growth factor-1 as a mechanistic target. Journal Of Nutrition, 134,. https://doi.org/10.1093/jn/134.9.2482S9, pp. 2482S-2486S.

Bouwman, P., & Jonkers, J. (Feb. 2014). Molecular pathways: how can BRCA-mutated tumors become resistant to PARP inhibitors? Clinical Cancer Research, 20(3), 540–547. https://doi.org/10.1158/1078-0432.CCR-13-0225

Qu, H., Xia, Y., & Li, X. (2020). Recombinant Human p53 Adenovirus Injection (rAd-p53) Combined with Chemotherapy for 4 Cases of High-grade Serous Ovarian Cancer. Current Gene Therapy, 20(4), 313–320. https://doi.org/10.2174/1566523220666200826100245

Article  CAS  PubMed  Google Scholar 

Papachristodoulou, A., et al. (Sep. 2021). NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation. Cancer Discovery, 11(9), 2316–2333. https://doi.org/10.1158/2159-8290.CD-20-1765

Kersten, K., de Visser, K. E., van Miltenburg, M. H., & Jonkers, J. (Feb. 2017). Genetically engineered mouse models in oncology research and cancer medicine. Embo Molecular Medicine, 9(2), 137–153. https://doi.org/10.15252/emmm.201606857

Jain, S., Patil, S. R., Swarnakar, N. K., & Agrawal, A. K. (2012). Oral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes), Mol Pharm, vol. 9, no. 9, pp. 2626–2635, Sep. https://doi.org/10.1021/mp300202c

Buters, J., et al. (Feb. 2003). CYP1B1 determines susceptibility to low doses of 7,12-dimethylbenz[a]anthracene-induced ovarian cancers in mice: correlation of CYP1B1-mediated DNA adducts with carcinogenicity. Carcinogenesis, 24(2), 327–334. https://doi.org/10.1093/carcin/24.2.327

Bhattacharyya, S. S., Paul, S., Mandal, S. K., Banerjee, A., Boujedaini, N., & Khuda-Bukhsh, A. R. (2009). A synthetic coumarin (4-methyl-7 hydroxy coumarin) has anticancer potentials against DMBA-induced skin cancer in mice, Eur J Pharmacol, vol. 614, no. 1–3, pp. 128–136, Jul. https://doi.org/10.1016/j.ejphar.2009.04.015

Daniel, P. M., Prichard, M. M., & THREE TYPES OF MAMMARY TUMOUR INDUCED IN RATS BY FEEDING WITH DMBA. (1964). Sep.,, Br J Cancer, vol. 13, no. 3, pp. 513–520. https://doi.org/10.1038/bjc.1964.58

Young, S., & Cowan, D. M. (1963). Spontaneous regression of induced mammary tumors in rats, Br J Cancer, vol. 17, no. 1, pp. 85–89, Mar. https://doi.org/10.1038/bjc.1963.13

Kushwah, V., Jain, D. K., Agrawal, A. K., & Jain, S. (Dec. 2018). Improved antitumor efficacy and reduced toxicity of docetaxel using anacardic acid functionalized stealth liposomes. Colloids And Surfaces. B, Biointerfaces, 172, 213–223. https://doi.org/10.1016/j.colsurfb.2018.08.047

Tikoo, K., Kumar, P., & Gupta, J. (Apr. 2009). Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benzanthracene (DMBA) induced breast cancer rats. Bmc Cancer, 9, 107. https://doi.org/10.1186/1471-2407-9-107

Kapadia, G. J., et al. (Feb. 2003). Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skin carcinogenesis, and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot. Pharmacological Research, 47(2), 141–148. https://doi.org/10.1016/s1043-6618(02)00285-2

Becci, P. J., Thompson, H. J., Grubbs, C. J., Brown, C. C., & Moon, R. C. (1979). Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat, Cancer Res, vol. 39, no. 8, pp. 3141–3144, Aug.

Yang, M., Tanaka, T., Hirose, Y., Deguchi, T., Mori, H., & Kawada, Y. (Nov. 1997). Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. International Journal Of Cancer, 73(5), 719–724. https://doi.org/10.1002/(sici)1097-0215)73:5%3C719::aid-ijc18%3E3.0.co;2-0.

Shirai, T., Fukushima, S., Ikawa, E., Tagawa, Y., & Ito, N. (1986). Induction of prostate carcinoma in situ at high incidence in F344 rats by a combination of 3,2’-dimethyl-4-aminobiphenyl and ethinyl estradiol, Cancer Res, vol. 46, no. 12 Pt 1, pp. 6423–6426, Dec.

Shirai, T., Sakata, T., Fukushima, S., Ikawa, E., & Ito, N. (1985). Rat prostate as one of the target organs for 3,2’-dimethyl-4-aminobiphenyl-induced carcinogenesis: effects of dietary ethinyl estradiol and methyltestosterone, Jpn J Cancer Res, vol. 76, no. 9, pp. 803–808, Sep.

Gurley, K. E., Moser, R. D., & Kemp, C. J. (2015). Induction of Liver Tumors in Mice with N-Ethyl-N-Nitrosourea or N-Nitrosodiethylamine, Cold Spring Harb Protoc, vol. 2015, no. 10, pp. 941–942, Oct. https://doi.org/10.1101/pdb.prot077438

Liu, Y., et al. (Oct. 2015). Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research. Quant Imaging Med Surg, 5(5), 708–729. https://doi.org/10.3978/j.issn.2223-4292.2015.06.01

Souto, E. P., Dobrolecki, L. E., Villanueva, H., Sikora, A. G., & Lewis, M. T. (2022). In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts, J Mammary Gland Biol Neoplasia, vol. 27, no. 2, pp. 211–230, Jun. https://doi.org/10.1007/s10911-022-09520-y

Cekanova, M., & Rathore, K. (2014). Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Design, Development And Therapy, 8, 1911–1921. https://doi.org/10.2147/DDDT.S49584

Article  PubMed  PubMed Central  Google Scholar 

Dickinson, J., de Matas, M., Dickinson, P. A., & Mistry, H. B. (2021). Exploring a model-based analysis of patient derived xenograft studies in oncology drug development. PeerJ, 9, e10681. https://doi.org/10.7717/peerj.10681

Article  PubMed  PubMed Central  Google Scholar 

Jin, J., Yoshimura, K., Sewastjanow-Silva, M., Song, S., & Ajani, J. A. (Jan. 2023). Challenges and Prospects of Patient-Derived Xenografts for Cancer Research. Cancers, 15(17), 4352. https://doi.org/10.3390/cancers15174352

Sobczuk, P., et al. (Mar. 2020). Choosing The Right Animal Model for Renal Cancer Research. Translational Oncology, 13(3), 100745. https://doi.org/10.1016/j.tranon.2020.100745

Jin, J., Yoshimura, K., Sewastjanow-Silva, M., Song, S., & Ajani, J. A. (Aug. 2023). Challenges and Prospects of Patient-Derived Xenografts for Cancer Research. Cancers (Basel), 15(17), 4352. https://doi.org/10.3390/cancers15174352

Al-Sudani, H., et al. (Jul. 2023). Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition. npj Precis Onc, 7(1), 69. https://doi.org/10.1038/s41698-023-00418-4

Liu, Y., Wu, W., Cai, C., Zhang, H., Shen, H., & Han, Y. (Apr. 2023). Patient-derived xenograft models in cancer therapy: technologies and applications. Sig Transduct Target Ther, 8(1), 160. https://doi.org/10.1038/s41392-023-01419-2

Callahan, R., & Smith, G. H. (2000). MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways, Oncogene, vol. 19, no. 8, pp. 992–1001, Feb. https://doi.org/10.1038/sj.onc.1203276

Dudley, J. P., Golovkina, T. V., & Ross, S. R. (2016). Lessons Learned from Mouse Mammary Tumor Virus in Animal Models. Ilar Journal, 57(1), 12–23. https://doi.org/10.1093/ilar/ilv044

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suga, T. (1991). Nov., Infection of rats with HTLV-1: a small-animal model for HTLV-1 carriers, Int J Cancer, vol. 49, no. 5, pp. 764–769. https://doi.org/10.1002/ijc.2910490522

Ahmed, E. H., & Baiocchi, R. A. (2016). Murine Models of Epstein–Barr Virus-Associated Lymphomagenesis. Ilar Journal, 57(1), 55–62. https://doi.org/10.1093/ilar/ilv074

Article  CAS  PubMed  PubMed Central  Google Scholar 

da Torres, M. K., dos, G., Pereira Neto, S., Cayres Vallinoto, I. M. V., Reis, L. O., & Vallinoto, A. C. R. (2025). The Impact of Oncogenic Viruses on Cancer Development: A Narrative Review, Biology (Basel), vol. 14, no. 7, p. 797, Jul. https://doi.org/10.3390/biology14070797

de Gruijl, F. R. (Dec. 1999). Skin cancer and solar UV radiation. European Journal Of Cancer, 35(14), 2003–2009. https://doi.org/10.1016/s0959-8049(99)00283-x

Barcellos-Hoff, M. H., & Ravani, S. A. (2000). Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells, Cancer Res, vol. 60, no. 5, pp. 1254–1260, Mar.

Hong, J. T., et al. (2001). Inhibitory effect of glycolic acid on ultraviolet-induced skin tumorigenesis in SKH-1 hairless mice and its mechanism of action. Molecular Carcinogenesis, 31(3), 152–160. https://doi.org/10.1002/mc.1050

Article  CAS  PubMed